Evidence map›Paper›PMID 37225938›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2023

Developing and characterizing monoclonal antibodies of Guertu bandavirus nucleoprotein for developing methods of Guertu bandavirus and severe fever with thrombocytopenia syndrome virus detection.

Jin Qian, Liyan Fu, Xiaoli Wu, Zhiying Wang, Hualin Wang, Yan Zeng, Guirong Cheng, Fei Deng, Shu Shen

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jin Qian *Brain Science and Advanced Technology Institute, Wuhan University of Science and Technology, Wuhan, 430065, China.
Liyan Fu *Brain Science and Advanced Technology Institute, Wuhan University of Science and Technology, Wuhan, 430065, China.
Xiaoli WuKey Laboratory of Special Pathogens and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Zhiying WangKey Laboratory of Special Pathogens and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Hualin WangKey Laboratory of Special Pathogens and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.
Yan ZengBrain Science and Advanced Technology Institute, Wuhan University of Science and Technology, Wuhan, 430065, China.
Guirong ChengBrain Science and Advanced Technology Institute, Wuhan University of Science and Technology, Wuhan, 430065, China. chengguirong@wust.edu.cn.
Fei DengKey Laboratory of Special Pathogens and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China. df@wh.iov.cn.
Shu ShenKey Laboratory of Special Pathogens and Biosafety and National Virus Resource Center, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China. shenshu@wh.iov.cn.ORCID http://orcid.org/0000-0002-0013-5365
Chinese Academy of Sciences · CNWuhan University of Science and Technology · CN

Funding

EVAg-Global project 871029Key Technologies Research and Development Program 2018YFE0200400National Natural Science Foundation of China U20A20135
6 · The paper itself

Abstract

Belonging to genus Bandavirus in Phenuiviridae family, Guertu bandavirus (GTV) is a potential pathogen closely related to severe fever with thrombocytopenia syndrome virus (SFTSV) and heartland virus (HRTV) associated with human diseases. Although the medical significance of GTV is not clear, there was serological evidence suggesting past infection with this virus has occurred, indicating its potential threat to human health. So, it is important to prepare for detection of GTV infection so as to control virus transmission and promote disease diagnosis and treatment. This study is aimed at obtaining monoclonal antibodies (mAbs) against GTV nucleoprotein (NP) and evaluating their activities in recognizing viral antigens from genetic-related bandaviruses, SFTSV and HRTV. Eight mAbs were obtained and four of them (22G1, 25C2, 25E2, and 26F8) recognize linear epitopes of GTV NP. The four mAbs showed cross-reactivity to SFTSV but were unable to react with HRTV. Two fine epitopes were identified by the four mAbs, E

Indexed as

PhlebovirusRNA VirusesSevere Fever with Thrombocytopenia SyndromeAntibodies, MonoclonalBunyaviridaeEpitopesHumansNucleoproteinsAntibodies, MonoclonalEpitopesNucleoproteinsCross-reactionGuertu bandavirusMonoclonal antibodyNucleoproteinSevere fever with thrombocytopenia syndrome virus

Identifiers

PMID37225938
PMCPMC10485201
OpenAlexW4377966814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.